Using Serum Her2 levels to monitor response to neoadj chemo

[Hopeful]

Abstract:

http://www.abstracts2view.com/sabcs10/view.php?nu=SABCS10L_379

Poster:

http://www.abstracts2view.com/sabcs10/viewp.php?nu=P3-01-03

Hopeful

[Rich66]

Conclusions: Prechemotherapy serum Her-2/neu was to be a significant predictor of pathologic response to neoadjuvant chemotherapy. Serum Her-2/neu levels during treatment were associated with pathologic response in patients receiving neoadjuvant chemotherapy, particularly, in trastuzumab-based regimen. Serum Her-2/neu levels may serve to monitoring neoadjuvant therapy in Her-2/neu overexpressed breast cancer.